confirms although related do not walk hand by hand... question: in general how gold mining stocks react to dow, nasdaq, s&p500 indexes? opposite, the same direction or unrelated. i had the impression to opposite, but getting confused recently.
kipk, agree, however, the general market conditions were very favorable to biotech at that time. now is different measure... investors are not keen to biotech as it needs long time of return and the probability of success is not that high. ok, OCAT product showed highly promising, but as you see even here, people who have no clue in science do not believe it. otherwise, i'd love to see the share price as high as it can go.... :-) and would love to have access to the product.
very good. however, should also account for affordability.
(to clarify -- I've been long on this for at least 10 years, with reducing at highs and adding back at lows or vice versa, but will sell all if it reaches over 30 in near future)
100B, come down to your senses. No pharma gives such premium. at 1B, which might be underestimate, but realistic at this time, OCAT will be around 20/share
there were over 150K shares sold at noon and similar number at 1:40pm, also yesterday at 11:30am. huh, even the timing is chosen at round minute... the game continues...
it's been known to run huge in the past and will do it again. the reals question is when will run up consistently without falling after the short cover rally. the product is wonderful, matter is in financing until gets out on the market.
dave, I'd love to see your prediction getting true, but it makes good to no one just projecting low probability actions. DRYS seems to be in 40-50 c trading range for some time, I like the drying volume though, sellers are getting washed out slowly but consistently.